- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03717324
Identifying Improvements in an ED Elder Friendly Area Based on Patient Experience (EDEFA_TheirVoice Project) (TheirVoice)
Identifying Improvements in an Emergency Department Elder Friendly Area Based on Patient Experience (EDEFA_TheirVoice Project)
Analyze patient experience of elders admitted to the Emergency Department Elder Friendly Area (EFA) and determine possible improvement options and potential solutions.
The project will use a creative problem-solving methodology (Design Thinking) to analyze the care process based on the experience of Elder Friendly Area (EFA) users and their families
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Method: This is a qualitative and quantitative evaluation project. The project will use a creative problem-solving methodology (Design Thinking) to analyze the care process based on the experience of Elder Friendly Area (EFA) users and their families. Design Thinking is a creativity and innovation methodology that compiles tools based on design principles for problem solving. It is characterized by having the ability to mix convergent and divergent thinking, reconciling rational and intuitive thinking. This methodology consists of 4 phases: Mapping, Exploring, Building and Testing. In each of them, the tools and techniques help us to observe, get involved and immerse ourselves in the patient's ecosystem, with the aim of designing a solution WITH the user and not just FOR him. Consequently, the error is reduced and the modifications and improvements of our projects are speeded up.
Patients: Patients/caregivers attended in the Emergency Department's EFA will participate . In the first fieldwork, 50-60 patients will participate, conducting a self-completed interview (prior informed consent, 10 minutes long).
In the qualitative research phase, 5-10 patients/caregivers conduct a 30-minute interview with the Design Thinking professional. The co-creation workshop lasts a couple of hours and 5 to 10 patients/caregivers will participate. In the second fieldwork another 50-60 patients will participate. In total, between 110 and 140 patients will be enrolled.
Ethics: Patients/caregivers will be provided with a patient information sheet and informed consent prior to participation. Patient experience data will be collected by Design Thinking professional on an anonymous basis and will always be handled on an aggregate basis.
Funding: The project will be developed in collaboration with Merck Sharp & Dohme Spain, with which there is an agreement signed (Fundació de Gestió HSCSP - MSD). For the correct development of it, MSD has hired a company expert in the development of this type of dynamics (Thinkers&Co) which will participate actively in all meetings and workshops and will be responsible for collecting the opinion of the patient anonymously and manage this information in an aggregate way, always with the intention of identifying the points of improvement on which later health professionals will work with the methodology described. However, no monetary payment will be made to the hospital, to the emergency department or to the professionals involved. The collaboration of MSD and Thinkers&Co will not affect the independent nature of the project.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Mireia Puig, PhD
- Phone Number: +34616335291
- Email: mpuigc@santpau.cat
Study Contact Backup
- Name: Mireia Puig
Study Locations
-
-
-
Barcelona, Spain, 08025
- Recruiting
- Hospital de la Santa Creu I Sant Pau
-
Contact:
- Mireia Puig, PhD
- Phone Number: +34616335291
- Email: mpuigc@santpau.cat
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- All patients attended in elder friendly area who agree to participate and their caregivers
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
First evaluation group (survey_1)
Patients/caregivers attended in the Emergency Department Elder Friendly Area (EFA)
|
|
Co-creation group
Patients/caregivers attended in the Emergency Department Elder Friendly Area (EFA) who want to participate in the co-creation workshop
|
Interventions will be those obtained from the co-creation workshop with patients
|
Second evaluation group (survey_2)
Patients/caregivers attended in the Emergency Department Elder Friendly Area (EFA), after improvements are made
|
Interventions will be those obtained from the co-creation workshop with patients
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quantitative improvement in the satisfaction survey
Time Frame: 1 month
|
A quantitative increase in the satisfaction survey obtained after the improvement implemented after the co-creation workshop.
|
1 month
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Mireia Puig, Hospital de la Santa Creu i Sant Pau, Emergency Department
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IIBSP-EXP-2018-80
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Emergencies
-
Betsi Cadwaladr University Health BoardRecruitingMedical EmergenciesUnited Kingdom
-
Central Hospital, Nancy, FranceCompleted
-
Universidad de AntioquiaCompleted
-
Second Affiliated Hospital, School of Medicine,...UnknownMedical EmergenciesChina
-
Technische Universität DresdenCompletedPerformance in Simulated Emergencies | Stress During Simulator Scenario | Behaviour of Physicians in Simulated EmergenciesGermany
-
Charite University, Berlin, GermanyZentralinstitut für die Kassenärztliche Versorgung in DeutschlandUnknownNon-urgent EmergenciesGermany
-
Peking University People's HospitalBeijing Emergency Medical Center; Beijing Red Cross Emergency CenterCompletedEmergencies [Disease/Finding]China
-
M.D. Anderson Cancer CenterRecruitingOncologic Complications and EmergenciesUnited States
-
Copenhagen Academy for Medical Education and SimulationCompletedCardiopulmonary Resuscitation | Education | Medical Emergencies
-
Chinese University of Hong KongUnknownEmergencies | Cancer | Oncologic Complications and EmergenciesChina
Clinical Trials on Procedure created in co-creation group
-
CardiacSense Ltd.Completed
-
Medical University of LodzCompletedCataract | Corneal Astigmatism | Corneal Incision Contracture
-
Instituto de Investigación Marqués de ValdecillaHospital de laredo; Hospital SierrallanaRecruiting
-
The Cleveland ClinicMerck Sharp & Dohme LLCNot yet recruiting
-
Farma de Colombia SACompletedHypertensionColombia, Ecuador
-
Memorial Sloan Kettering Cancer CenterCompletedThyroid Cancer | Papillary MicrocarcinomaUnited States
-
University of WashingtonBreast Cancer Research FoundationNot yet recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic HER2-Negative Breast Carcinoma | Metastatic Hormone Receptor-Positive Breast Carcinoma | Locally Advanced Unresectable HER2-Negative Breast Carcinoma | Locally Advanced Unresectable Hormone Receptor-Positive...United States